NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer

NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer

Abstract Sanjay M. Desai Objectives Epithelial ovarian cancer (EOC) is a heterogeneous, essentially peritoneal disease. Standard treatment consists of staging, cytoreductive surgery (CRS), and adjuvan...

Full description

Bibliographic Details
Main Authors:	Elroy Saldanha, Sanjay M. Desai, Dhruv G. Patel, Vinod Dhakad, Bonny Joseph, Sandeep Ghosh, Varun Prakash, Harsha Deepti, Ashma Monteiro
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2023-01-01
Series:	South Asian Journal of Cancer
Subjects:	epithelial ovarian cancers cytoreduction intraperitoneal chemotherapy cisplatin paclitaxel disease-free survival
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1751098

Similar Items

Severe hypertriglyceridemia during treatment with intraperitoneal cisplatin and paclitaxel for advanced stage fallopian tube carcinoma
by: Megan Lander, et al.
Published: (2020-05-01)

Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae
by: Alonso Anais, et al.
Published: (2022-05-01)

Specific features of current intraperitoneal therapy in patients with ovarian cancer
by: A. G. Kedrova, et al.
Published: (2016-06-01)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023-03-01)

Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer
by: Shen Zhao, et al.
Published: (2022-09-01)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021-01-01)

Intraperitoneal CHEMOPERFUSION TREATMENT OF ADVANCED OVARIAN CANCER WITH DIOXADET COMPARED TO CISPLATIN in experimental s
by: V. G. Bespalov, et al.
Published: (2016-02-01)

A prospective comparative study of concurrent chemoradiation in advanced carcinoma cervix patients with weekly cisplatin vs. weekly cisplatin and paclitaxel
by: Amit K Mukherjee, et al.
Published: (2022-01-01)

Assessment of nephrotoxicity associated with combined cisplatin and mitomycin C usage in laparoscopic hyperthermic intraperitoneal chemotherapy
by: Ravish Kapoor, et al.
Published: (2019-01-01)

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in management of peritoneal carcinomatosis: Single center experience in Korea
by: Hee Ju Lee, et al.
Published: (2019-12-01)

Safety of Health Workers During Hyperthermic Intraperitoneal Chemotherapy Procedure
by: Koray Topgül, et al.
Published: (2017-12-01)

Complete Response for More than 4 Years following Neoadjuvant FOLFOX and Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Patient with Advanced Gastric Cancer with Extensive Peritoneal Carcinomatosis
by: Renata D’Alpino Peixoto, et al.
Published: (2018-05-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique
by: Talgat Uskenbayev, et al.
Published: (2019-06-01)

Proteomic and metabolomic signatures of U87 glioblastoma cells treated with cisplatin and/or paclitaxel
by: Munazza Ahmed, et al.
Published: (2023-12-01)

Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial
by: Maheswari Senthil, et al.
Published: (2023-03-01)

Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities
by: Aruna Prabhu, et al.
Published: (2022-05-01)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

Tonic-Clonic Seizure following Cytoreductive Surgery with Intraperitoneal Oxaliplatin: A Case Report and Review of the Literature
by: Jessica Sayuri Tsukamoto, et al.
Published: (2016-02-01)

Efficacy and Safety of Conversion Therapy by Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal Metastasis: A Prospective Phase II Study
by: Zhong-Yin Yang, et al.
Published: (2022-06-01)

Risk factors of chronic kidney disease in cisplatin-based hyperthermia intraperitoneal chemotherapy
by: Chih-Chung Cheng, et al.
Published: (2024-12-01)

Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer
by: Dorsa Safari, et al.
Published: (2024-10-01)

The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maher Al Khaldi, et al.
Published: (2022-11-01)

Current clinical practices of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Acs Miklos, et al.
Published: (2024-03-01)

Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report
by: Yoshiyuki Meguro, et al.
Published: (2020-03-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis
by: Oleksandr Vadymovych Bondar, et al.
Published: (2021-12-01)

Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis
by: Guojun Yan, et al.
Published: (2024-09-01)

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Youngbae Jeon, et al.
Published: (2023-12-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignant tumors in children: Initial experience in a single institution
by: Zhiyun Zhu, et al.
Published: (2023-01-01)

Long-term survival outcomes following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of hepatocellular carcinoma patients
by: Guojun Yan, et al.
Published: (2024-05-01)

Combination of Cannabidiol with Cisplatin or Paclitaxel Analysis Using the Chou–Talalay Method and Chemo-Sensitization Evaluation in Platinum-Resistant Ovarian Cancer Cells
by: Jana Ismail, et al.
Published: (2025-02-01)

Cytoreductive Surgery and Hyperthermic İntraperitoneal Chemoterapy for Advance Gastric Cancer Associated Peritoneal Carcinomatosis Single Centre Unit for 10 Consecutive Patients
by: Özgül Düzgün, et al.
Published: (2019-09-01)

Assessing morbidity, mortality, and survival in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
by: JAIRO SEBASTIÁN ASTUDILLO VALLEJO, et al.
Published: (2023-04-01)

The real-world efficacy and toxicity of first-line paclitaxel and cisplatin with bevacizumab in platinum-naïve primary stage IVB cervical cancer
by: Junhwan Kim, et al.
Published: (2025-01-01)

Comparison of survival and adverse effect profile in patients with esophageal cancer treated with the combination of carboplatin and paclitaxel vs. 5-flourouracil and cisplatin
by: N. Nisar, et al.
Published: (2022-09-01)

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)
by: Falla-Zuniga Luis Felipe, et al.
Published: (2023-12-01)

Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011-12-01)

Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011-12-01)

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report
by: Nilanjana Howbora, et al.
Published: (2023-01-01)

Long‐term outcomes and survival analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei at a newly established peritoneal malignancy centre in Japan
by: Hideaki Yano, et al.
Published: (2024-07-01)